Revenue
0 USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Fundies. English
VIKING THERAPEUTICS, INC.
EDGARAnnual consolidated revenue for 2025: about USD 0, using the latest reported figures. The previous period, 2024, was about USD 0.
Latest quarter
- Cash and cash equivalents
- 678 million USD Source
Exact value
677609000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 128 million shares Source
Exact value
127521229 shares
Reported share-count change
13.41% · 15.1 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
0 USD
2025-10-01 – 2026-09-30
Net income
-627 million USD
2025-10-01 – 2026-09-30
Exact inputs and evidence
Operating cash flow
-463 million USD
2025-10-01 – 2026-09-30
Exact inputs and evidence
- Operating cash flow: -278685000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -193395000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -113976000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -239148000 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -113976000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -377342000 USD · 2026-01-01 – 2026-09-30 Source
- Operating cash flow: -239148000 USD · 2026-01-01 – 2026-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-29.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 11 of 11 periods available· newest 2025-12-31
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 11 of 11 periods available· newest 2025-12-31
- Total liabilities: 11 of 11 periods available· newest 2025-12-31
- Current assets: 11 of 11 periods available· newest 2025-12-31
- Current liabilities: 11 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 11 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
USD 0Prior period
USD 0
–
Current period
USD 0
–
Exact inputs and evidence
0 − 0 = 0 USD
0 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source0 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 249.68 millionPrior period
−USD 109.96 million
–
Current period
−USD 359.64 million
–
Exact inputs and evidence
-359639000 − -109963000 = -249676000 USD
-109963000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-359639000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 190.9 millionPrior period
−USD 87.79 million
–
Current period
−USD 278.69 million
–
Exact inputs and evidence
-278685000 − -87790000 = -190895000 USD
-87790000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-278685000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 0
- Operating costs Derived USD 393.34 million
- Operating income −USD 393.34 million
- Tax, interest and other Derived −USD 33.7 million
- Net income −USD 359.64 million
Cash
- Operating cash flow −USD 278.69 million
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2016 Not shown: operating income or net income is not reported.
- 2017 Not shown: operating income or net income is not reported.
- 2018 Not shown: operating income or net income is not reported.
- 2019 Not shown: operating income or net income is not reported.
- 2020 Not shown: operating income or net income is not reported.
- 2021 Not shown: operating income or net income is not reported.
- 2022 Not shown: operating income or net income is not reported.
- 2023 Not shown: operating income or net income is not reported.
- 2024 Not shown: operating income or net income is not reported.
- 2025 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | 0 | 13847275 Derived | -13847275 | 884547 Derived | -14731822 | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 0 | 19070000 Derived | -19070000 | 1508000 Derived | -20578000 | Unavailable | Source
|
| 2018 2018-01-01 – 2018-12-31 | 0 | 26161000 Derived | -26161000 | -4098000 Derived | -22063000 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 0 | 32687000 Derived | -32687000 | -6908000 Derived | -25779000 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 0 | 42662000 Derived | -42662000 | -3167000 Derived | -39495000 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 0 | 55682000 Derived | -55682000 | -692000 Derived | -54990000 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 0 | 70355000 Derived | -70355000 | -1488000 Derived | -68867000 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 0 | 100827000 Derived | -100827000 | -14932000 Derived | -85895000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 0 | 150921000 Derived | -150921000 | -40958000 Derived | -109963000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 0 | 393342000 Derived | -393342000 | -33703000 Derived | -359639000 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 0 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 0 |
|
| 2017 | Revenue | 0 |
|
| 2018 | Revenue | 0 |
|
| 2019 | Revenue | 0 |
|
| 2020 | Revenue | 0 |
|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 0 |
|
| 2023 | Revenue | 0 |
|
| 2024 | Revenue | 0 |
|
| 2025 | Revenue | 0 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | No prior comparable period |
|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | No prior comparable period |
|
| 2025 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | Not reported |
|
| 2017 | Operating margin | Not reported |
|
| 2018 | Operating margin | Not reported |
|
| 2019 | Operating margin | Not reported |
|
| 2020 | Operating margin | Not reported |
|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | Not reported |
|
| 2023 | Operating margin | Not reported |
|
| 2024 | Operating margin | Not reported |
|
| 2025 | Operating margin | Not reported |
|
| 2016 | Net margin | Not reported |
|
| 2017 | Net margin | Not reported |
|
| 2018 | Net margin | Not reported |
|
| 2019 | Net margin | Not reported |
|
| 2020 | Net margin | Not reported |
|
| 2021 | Net margin | Not reported |
|
| 2022 | Net margin | Not reported |
|
| 2023 | Net margin | Not reported |
|
| 2024 | Net margin | Not reported |
|
| 2025 | Net margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -278.7M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | -11071263 |
|
| 2017 | Operating cash flow | -14758000 |
|
| 2018 | Operating cash flow | -18755000 |
|
| 2019 | Operating cash flow | -24752000 |
|
| 2020 | Operating cash flow | -21777000 |
|
| 2021 | Operating cash flow | -47586000 |
|
| 2022 | Operating cash flow | -48397000 |
|
| 2023 | Operating cash flow | -73376000 |
|
| 2024 | Operating cash flow | -87790000 |
|
| 2025 | Operating cash flow | -278685000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
10.7% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 44.7% |
|
| 2017 | Liabilities / assets | 39.1% |
|
| 2018 | Liabilities / assets | 1.5% |
|
| 2019 | Liabilities / assets | 2.5% |
|
| 2020 | Liabilities / assets | 4.7% |
|
| 2021 | Liabilities / assets | 4.2% |
|
| 2022 | Liabilities / assets | 13.8% |
|
| 2023 | Liabilities / assets | 5.4% |
|
| 2024 | Liabilities / assets | 3.1% |
|
| 2025 | Liabilities / assets | 10.7% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
9.33× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 2.16× |
|
| 2017 | Current assets / current liabilities | 2.52× |
|
| 2018 | Current assets / current liabilities | 66.4× |
|
| 2019 | Current assets / current liabilities | 41.83× |
|
| 2020 | Current assets / current liabilities | 21.12× |
|
| 2021 | Current assets / current liabilities | 23.98× |
|
| 2022 | Current assets / current liabilities | 7.61× |
|
| 2023 | Current assets / current liabilities | 19.19× |
|
| 2024 | Current assets / current liabilities | 33.09× |
|
| 2025 | Current assets / current liabilities | 9.33× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | −USD 14.73 million Exact valueExact value: -14731822 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11.07 million Exact valueExact value: -11071263 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | −USD 20.58 million Exact valueExact value: -20578000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.76 million Exact valueExact value: -14758000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | −USD 22.06 million Exact valueExact value: -22063000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.76 million Exact valueExact value: -18755000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 25.78 million Exact valueExact value: -25779000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 24.75 million Exact valueExact value: -24752000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 39.5 million Exact valueExact value: -39495000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.78 million Exact valueExact value: -21777000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 54.99 million Exact valueExact value: -54990000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 47.59 million Exact valueExact value: -47586000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 68.87 million Exact valueExact value: -68867000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 48.4 million Exact valueExact value: -48397000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 85.9 million Exact valueExact value: -85895000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 73.38 million Exact valueExact value: -73376000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 109.96 million Exact valueExact value: -109963000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 87.79 million Exact valueExact value: -87790000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 359.64 million Exact valueExact value: -359639000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 278.69 million Exact valueExact value: -278685000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
63 filings · 2,385 latest values · 2,385 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001607678, 1607678, VKTX, edgar:1607678
Also known as VIKING THERAPEUTICS, INC., Viking Therapeutics, Inc.